Digital PCR Enables Breakthroughs in Quantitation and Monitoring
Genetic conditions impact lives in many different ways. From congenital anomalies such as spinal muscular atrophy (SMA) to drug-resistances that develop during chemotherapy, identifying the genetic cause can facilitate early intervention and better outcomes.
Digital PCR (dPCR) provides a quantitative approach to identifying gene deletions, copy number variations (CNVs), single nucleotide polymorphisms (SNPs), and more. Additionally, the sensitivity provided by dPCR makes the technique ideally suited for applications in cell-free fetal DNA (cffDNA) and graft-derived cell-free DNA (GcfDNA).